Differential expression of CD10 in prostate cancer and its clinical implication
<p>Abstract</p> <p>Background</p> <p>CD10 is a transmembrane metallo-endopeptidase that cleaves and inactivates a variety of peptide growth factors. Loss of CD10 expression is a common, early event in human prostate cancer; however, CD10 positive cancer cells frequently...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-03-01
|
| Series: | BMC Urology |
| Online Access: | http://www.biomedcentral.com/1471-2490/7/3 |